Tag Archives: FCNCA

Top Casino Stocks To Watch Right Now

With legalized sports gambling in the U.S. about to become a reality in many states, regional casino operator Boyd Gaming (NYSE:BYD) is gearing up to go on a spending spree. It just increased a debt offering from $500 million to $700 million and says a portion of the proceeds will be used for acquisitions.

Boyd hasn’t exactly been reticent when it comes to making acquisitions, and today owns or operates 24 gaming properties in seven states. Last December, it entered into an agreement with Penn National Gaming (NASDAQ:PENN) to buy four properties after Penn closes on its acquisition of Pinnacle Entertainment, and then two days later agreed to acquire Valley Forge Casino Resort in King of Prussia, Pennsylvania. Earlier this month it completed its acquisition of Lattner Entertainment, a bar and tavern gaming operator with some 220 locations across Illinois.

Boyd is also well established in the sports wagering market, having one of the largest sports books in Nevada, where betting on sports has been legal for decades. Boyd Gaming stands to be one of the big winners from the Supreme Court ruling because of its extensive experience and broad network of regional casinos that will bring sports gambling closer to more people.

Top Casino Stocks To Watch Right Now: PPL Corporation(PPL)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    That’s why investors would be better off investing in high-yielding Duke Energy Corporation (NYSE:DUK) or PPL Corporation (NYSE:PPL). Here’s what you need to know to decide.

  • [By ]

    If this is, indeed, the case, investors have a handful of high quality names at attractive prices to choose from. One that has popped up on my radar is PPL Corporation (NYSE: PPL).

  • [By Shane Hupp]

    PPL (NYSE:PPL) and IDACORP (NYSE:IDA) are both utilities companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.

Top Casino Stocks To Watch Right Now: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Max Byerly]

    Macquarie Group Ltd. purchased a new stake in B&G Foods, Inc. (NYSE:BGS) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 6,200 shares of the company’s stock, valued at approximately $185,000.

  • [By Max Byerly]

    B&G Foods (NYSE:BGS) has received a consensus rating of “Hold” from the twelve brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $34.38.

  • [By ]

    B&G Foods (BGS) : “No, we’re going to stay away. This group is a snake pit.”

    Masco (MAS) : “I like Masco. We have a housing shortage and that’s good for Masco.”

  • [By Ethan Ryder]

    A number of research firms recently commented on BGS. BMO Capital Markets decreased their target price on B&G Foods from $33.00 to $28.00 and set a “market perform” rating for the company in a report on Thursday. Barclays reaffirmed a “hold” rating and set a $23.00 target price on shares of B&G Foods in a report on Thursday. Zacks Investment Research raised B&G Foods from a “sell” rating to a “hold” rating in a report on Monday, January 7th. ValuEngine downgraded B&G Foods from a “hold” rating to a “sell” rating in a report on Thursday, January 24th. Finally, Credit Suisse Group decreased their target price on B&G Foods from $23.00 to $19.00 and set an “underperform” rating for the company in a report on Wednesday. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company’s stock. B&G Foods currently has a consensus rating of “Hold” and an average price target of $29.28.

    TRADEMARK VIOLATION WARNING: “Wellington Shields Capital Management LLC Sells 600 Shares of B&G Foods, Inc. (BGS)” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at www.tickerreport.com/banking-finance/4191517/wellington-shields-capital-management-llc-sells-600-shares-of-bg-foods-inc-bgs.html.

    B&G Foods Profile

  • [By Motley Fool Transcribing]

    B & G Foods (NYSE:BGS) Q4 2018 Earnings Conference CallFeb. 26, 2019 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Casino Stocks To Watch Right Now: First Citizens BancShares, Inc.(FCNCA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Capital City Bank Group (NASDAQ: CCBG) and First Citizens BancShares (NASDAQ:FCNCA) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

  • [By Max Byerly]

    American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Bessemer Group Inc. reduced its position in First Citizens BancShares Inc. (NASDAQ:FCNCA) by 6.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,400 shares of the bank’s stock after selling 300 shares during the quarter. Bessemer Group Inc.’s holdings in First Citizens BancShares were worth $1,659,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    First Citizens BancShares Inc. Class A (NASDAQ:FCNCA) was upgraded by equities researchers at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

Hot Performing Stocks To Buy For 2019

Arconic (NYSE:ARNC) stock was on the rise Monday following talk about a possible buyout of the company.

Source: Shutterstock

A recent report claims that Arconic is a strong target for a buyout from several private equity firms. Among these firms that may have an interest in obtaining the producer of airplane parts is Apollo Global Management LLC.

According to these reports, Arconic is an attractive acquisition target for private equity firms due to its lacking cash generation and current valuation. This would allow these private equity firms to have easy enter and exit points in connection to buying and selling the company.

All of this talk about a private equity firm scooping up Arconic comes as it struggles to turn its business around. The company’s not been performing well lately and new CEO Chip Blankenship has been considering what to do with it. He plans to complete his review of the company this quarter, reports Bloomberg.

Hot Performing Stocks To Buy For 2019: Helix Energy Solutions Group, Inc.(HLX)

Advisors’ Opinion:

  • [By Max Byerly]

    Helix Energy Solutions Group Inc (NYSE:HLX) VP Alisa B. Johnson sold 15,244 shares of the business’s stock in a transaction on Tuesday, September 25th. The stock was sold at an average price of $9.85, for a total value of $150,153.40. Following the completion of the sale, the vice president now directly owns 285,480 shares in the company, valued at $2,811,978. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Helix Energy Solutions Group (HLX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    A number of institutional investors have recently bought and sold shares of the stock. Macquarie Group Ltd. increased its position in Helix Energy Solutions Group by 1.1% in the fourth quarter. Macquarie Group Ltd. now owns 4,442,065 shares of the oil and gas company’s stock worth $24,031,000 after buying an additional 46,900 shares in the last quarter. Municipal Employees Retirement System of Michigan purchased a new stake in Helix Energy Solutions Group in the fourth quarter worth about $263,000. Gotham Asset Management LLC purchased a new stake in Helix Energy Solutions Group in the fourth quarter worth about $1,922,000. Metropolitan Life Insurance Co. NY increased its position in Helix Energy Solutions Group by 397.2% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 47,600 shares of the oil and gas company’s stock worth $258,000 after buying an additional 38,026 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. increased its position in Helix Energy Solutions Group by 22.8% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 145,536 shares of the oil and gas company’s stock worth $787,000 after buying an additional 27,016 shares in the last quarter. Institutional investors own 94.63% of the company’s stock.

    WARNING: “Helix Energy Solutions Group (HLX) Shares Down 7.2%” was published by Ticker Report and is owned by of Ticker Report. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at www.tickerreport.com/banking-finance/4164538/helix-energy-solutions-group-hlx-shares-down-7-2.html.

    Helix Energy Solutions Group Company Profile (NYSE:HLX)

  • [By Ethan Ryder]

    Helix Energy Solutions Group (NYSE:HLX) had its price target reduced by equities researchers at Cowen from $11.00 to $10.00 in a research note issued to investors on Thursday. The brokerage currently has an “outperform” rating on the oil and gas company’s stock. Cowen’s target price indicates a potential upside of 37.93% from the stock’s current price.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Helix Energy Solutions Group (HLX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Helix Energy Solutions Group Inc (NYSE:HLX) has been given an average recommendation of “Buy” by the nine analysts that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $9.20.

Hot Performing Stocks To Buy For 2019: First Citizens BancShares, Inc.(FCNCA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Capital City Bank Group (NASDAQ: CCBG) and First Citizens BancShares (NASDAQ:FCNCA) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

  • [By Max Byerly]

    American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    First Citizens BancShares Inc. Class A (NASDAQ:FCNCA) was upgraded by equities researchers at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

Hot Performing Stocks To Buy For 2019: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) rose over 26% today after the company reported that Europe’s Committee for Medicinal Products for Human Use (CHMP) voted to recommend Zynquista in patients with type 1 diabetes. The news comes less than two months after an advisory committee to the U.S. Food and Drug Administration reached an impasse on recommending the drug in the same patient population, with eight members in favor and eight members against. 

  • [By Keith Speights, Sean Williams, and Brian Feroldi]

    But with problems come opportunities. Many companies focus on developing drugs and medical devices that help patients manage diabetes. We asked three Motley Fool healthcare contributors to identify the diabetes stocks that they would recommend investors watch closely in February. Here’s why they chose Insulet (NASDAQ:PODD), Lexicon Pharmaceuticals (NASDAQ:LXRX), and Tandem Diabetes Care (NASDAQ:TNDM).

  • [By Shane Hupp]

    Lexicon Pharmaceuticals (NASDAQ:LXRX) – Analysts at Wedbush issued their Q1 2019 earnings per share (EPS) estimates for Lexicon Pharmaceuticals in a note issued to investors on Monday, May 7th. Wedbush analyst L. Moussatos expects that the biopharmaceutical company will earn ($0.28) per share for the quarter. Wedbush currently has a “Outperform” rating and a $40.00 target price on the stock. Wedbush also issued estimates for Lexicon Pharmaceuticals’ Q2 2019 earnings at ($0.25) EPS, Q3 2019 earnings at ($0.13) EPS, Q4 2019 earnings at ($0.06) EPS, FY2020 earnings at $0.53 EPS, FY2021 earnings at $2.22 EPS and FY2022 earnings at $3.81 EPS.

  • [By Chris Lange]

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) is making presentations at the American Diabetes Association on June 22 to 26. Lexicon recently traded at $12.92 a share, with a consensus price target of $23.00 and a 52-week range of $7.67 to $18.00.

Best Value Stocks To Own Right Now

Michael A. Robinson

I’ve recently been thinking a lot about the day the stock market crashed in October 1987.

You know why…

On Oct. 19, 1987 – Black Monday – the Dow Jones Industrial Average lost 22.6% of its value in a single day.

And ever since Jan. 26, we’ve seen the Dow drop 10%, regain half of that, and then drop and bounce back some again and again.

Back in 1987, I was a banking and technology analyst working in San Francisco’s financial district. My boss called me from New York after the market closed on Black Monday to talk it over.

Best Value Stocks To Own Right Now: Arrow Electronics, Inc.(ARW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PNC Financial Services Group Inc. increased its holdings in Arrow Electronics, Inc. (NYSE:ARW) by 29.7% in the first quarter, HoldingsChannel.com reports. The firm owned 19,225 shares of the technology company’s stock after buying an additional 4,405 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Arrow Electronics were worth $1,480,000 at the end of the most recent reporting period.

  • [By Lee Jackson]

    This award-winning company looks poised to come in strong for the quarter. Arrow Electronics Inc. (NYSE: ARW) is a worldwide provider of products, services and solutions to industrial and commercial users of electronic components and enterprise computing solutions.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Arrow Electronics (ARW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Arrow Electronics (NYSE:ARW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Arrow Electronics reported better-than-expected results for first-quarter 2018. The figures also came above the mid-point of the company’s guidance ranges and marked year-over-year improvement. Moreover, the electronic component distributor provided an optimistic guidance for second-quarter 2018. We believe that the company’s core strength in providing best-in-class services and easy-to-acquire technologies should drive growth in the long run. Moreover, the company has secured a significant market share through a broad portfolio of products and services, and continued efforts to maximize consumer satisfaction. Additionally, incremental sales from strategic acquisitions and partnerships are expected to boost the top line. However, an uncertain economic environment, high debt burden and competition remain the concerns. Notably, the stock has outperformed the industry in the last one year.”

Best Value Stocks To Own Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Shane Hupp]

    News articles about Achillion Pharmaceuticals (NASDAQ:ACHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achillion Pharmaceuticals earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.941587509483 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Best Value Stocks To Own Right Now: NeuroMetrix Inc.(NURO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Haemonetics (NYSE: HAE) and Neurometrix (NASDAQ:NURO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations.

  • [By Logan Wallace]

    Obalon Therapeutics (NASDAQ: OBLN) and Neurometrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability.

Best Value Stocks To Own Right Now: First Citizens BancShares, Inc.(FCNCA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Capital City Bank Group (NASDAQ: CCBG) and First Citizens BancShares (NASDAQ:FCNCA) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

  • [By Max Byerly]

    American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

Best Value Stocks To Own Right Now: Masimo Corporation(MASI)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    So while Fischer is pitching cloud software company AppFolio (NASDAQ:APPF)and Bush suggests cybersecurity player Carbon Black(NASDAQ:CBLK), Moser is going with a healthcare basket: insurer UnitedHealth Group(NYSE:UNH) big dog, medical device maker Masimo(NASDAQ:MASI), pet-focused Idexx Labs(NASDAQ:IDXX), and remote medicine leader Teladoc(NYSE:TDOC).

  • [By VantagePoint]

    Masimo Corporation (NASDAQ: MASI) had a predictive moving average crossover to the upside in early-April indicating a bullish trend. As soon as the blue line crossed above the black line, VantagePoint users knew they should start taking long positions in this market. The Neural Index also supported that move to the upside. In 18 trading days, $MASI was up almost 14 percent or $11.77 per share.

  • [By Max Byerly]

    Masimo Co. (NASDAQ:MASI) Director Steven Barker sold 10,000 shares of the stock in a transaction on Wednesday, May 30th. The stock was sold at an average price of $100.00, for a total value of $1,000,000.00. Following the completion of the transaction, the director now directly owns 73,249 shares of the company’s stock, valued at approximately $7,324,900. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Best Medical Stocks For 2019

Amazon.com, Inc. (NASDAQ:AMZN) has been one of the more impressive stocks of the past 25 years. In fact, AMZN now has returned nearly 100,000% from its IPO price of $18 ($1.50 adjusted for the company’s subsequent stock splits).

A large part of the returns have come from two factors. First, Amazon has vastly expanded its reach. What originally was just an online bookseller now has its hands in everything from cloud computing to online media to groceries. And its shadow is even larger. A potential entry by Amazon has rattled pharmacy stocks and medical distributors, among others.

Secondly, as a stock, AMZN has managed the feat of keeping a growth stock valuation for over two decades. I’ve long argued that investors can’t focus solely on the company’s high P/E ratio to value Amazon stock. But however wise an investor might the current multiple is, the market has assigned a substantial premium to AMZN stock for over 20 years now.

It’s an impressive combination — and one that’s likely impossible, or close, to duplicate. But these five stocks have the potential to at least replicate parts of the Amazon formula. All five have years, if not decades, of growth ahead. New market opportunities abound. And while I’m not predicting that any will rise 100,000% — or 1,000% — these five stocks do have the potential for impressive long-term gains.

Best Medical Stocks For 2019: Frequency Electronics Inc.(FEIM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Frequency Electronics (NASDAQ:FEIM) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Frequency Electronics earned a news impact score of 0.15 on Accern’s scale. Accern also assigned media headlines about the communications equipment provider an impact score of 46.4556074629456 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Best Medical Stocks For 2019: BlackLine, Inc. (BL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BlackLine (BL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By WWW.GURUFOCUS.COM]

    For the details of Silver Lake Group, L.L.C.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Silver+Lake+Group%2C+L.L.C.

    These are the top 5 holdings of Silver Lake Group, L.L.C.GoDaddy Inc (GDDY) – 15,868,908 shares, 21.3% of the total portfolio. Alibaba Group Holding Ltd (BABA) – 3,587,218 shares, 16.52% of the total portfolio. Sabre Corp (SABR) – 30,019,094 shares, 16.43% of the total portfolio. Broadcom Ltd (AVGO) – 1,618,567 shares, 11.1% of the total portfolio. BlackLine Inc (BL) – 12,543,873 shares, 10.99% of the total portfolio. Share

  • [By Motley Fool Staff]

    The period-end close is a time-consuming and frustrating process that accountants in nearly every business have to deal with on a regular basis. BlackLine (NASDAQ:BL) is a software-as-a-service provider that brings order to this chaotic affair through automation. Businesses everywhere have been flocking to the service in an effort to bring their accounting process into the 21st century.

  • [By WWW.GURUFOCUS.COM]

    For the details of Silver Lake Group, L.L.C.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Silver+Lake+Group%2C+L.L.C.

    These are the top 5 holdings of Silver Lake Group, L.L.C.GoDaddy Inc (GDDY) – 15,868,908 shares, 21.3% of the total portfolio. Alibaba Group Holding Ltd (BABA) – 3,587,218 shares, 16.52% of the total portfolio. Sabre Corp (SABR) – 30,019,094 shares, 16.43% of the total portfolio. Broadcom Ltd (AVGO) – 1,618,567 shares, 11.1% of the total portfolio. BlackLine Inc (BL) – 12,543,873 shares, 10.99% of the total portfolio. Share

  • [By Brian Feroldi, Keith Speights, and Neha Chamaria]

    So which stocks are likely to leave Apple in the dust from here? We asked three Motley Fool investors to weigh in and they picked Editas Medicine (NASDAQ:EDIT),A.O. Smith (NYSE:AOS), andBlackLine (NASDAQ:BL).

Best Medical Stocks For 2019: OneMain Holdings, Inc.(OMF)

Advisors’ Opinion:

  • [By Max Byerly]

    OneMain (NYSE: OMF) and Provident Financial (OTCMKTS:FPLPY) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

  • [By Max Byerly]

    Rhumbline Advisers boosted its position in shares of OneMain Holdings Inc (NYSE:OMF) by 18.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,772 shares of the financial services provider’s stock after acquiring an additional 9,479 shares during the period. Rhumbline Advisers’ holdings in OneMain were worth $1,790,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OneMain (OMF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks For 2019: America First Tax Exempt Investors L.P.(ATAX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of America First Tax Exempt Investors, L.P. (NASDAQ:ATAX) hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $6.47 and last traded at $6.43, with a volume of 54800 shares changing hands. The stock had previously closed at $6.43.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on America First Multifamily Investors (ATAX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks For 2019: First Citizens BancShares, Inc.(FCNCA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Capital City Bank Group (NASDAQ: CCBG) and First Citizens BancShares (NASDAQ:FCNCA) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

  • [By Max Byerly]

    American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.